サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1709464

医薬品分析試験アウトソーシングの世界市場：サービスの種類別・試験の種類別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, By Testing Type, By End-User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医薬品分析試験アウトソーシングの世界市場：サービスの種類別・試験の種類別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

医薬品分析試験アウトソーシングの市場規模は2024年に85億3,055万米ドルとなり、2025年から2032年にかけてCAGR 7.70％で拡大

医薬品分析試験アウトソーシングの市場力学

ジェネリック医薬品市場の拡大が分析試験ニーズを後押し

ジェネリック医薬品市場の拡大は、医薬品分析試験アウトソーシング市場の重要な促進要因です。手頃な価格の医薬品に対する需要が北米を中心に世界的に高まる中、製薬会社はジェネリック医薬品の開発にますます注力するようになっており、品質と規制遵守を確保するために厳格な分析試験が必要となっています。ジェネリック医薬品業界は製造コストの削減というメリットを享受しており、分析試験のアウトソーシングにより、企業は経費を抑制しながら高い水準を維持することができます。さらに、ジェネリック医薬品を迅速に市場に投入しなければならないというプレッシャーの高まりが、アウトソーシングの必要性をさらに高めています。第三者試験プロバイダーはスピードと専門知識を提供してくれるからです。米国FDAによると、米国では処方箋の90％以上がジェネリック医薬品で満たされており、膨大な市場規模とそれに対応する信頼性の高い効率的な試験の必要性が浮き彫りになっています。この動向は今後も続くと予想され、試験受託サービスへの需要を今後数年間は煽ることになります。

医薬品分析試験アウトソーシング市場：主な考察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2025-2032年）に約7.70%のCAGRで年間成長すると予測されています。

サービスの種類別では、品質管理試験が2024年に最大市場シェアを示すと予測されます。

試験の種類別では、完成品試験が2024年の主要試験タイプです。

エンドユーザー別では、製薬会社が2024年の主要エンドユーザーでした。

地域別では、北米が2024年の売上高をリードしています。

医薬品分析試験アウトソーシング市場：セグメンテーション分析

世界の医薬品分析試験アウトソーシング市場は、サービスの種類、試験の種類、エンドユーザー、地域に基づいてセグメント化されます。

市場はサービスの種類に基づいて6つに分類されます：品質管理試験、生物分析試験、安定性試験、試験法開発・検証、規制試験、微生物試験です。医薬品分析試験アウトソーシング市場では、品質管理試験が最も重要かつ支配的なセグメントです。これは、医薬品が市場に出回る前に、安全性、有効性、品質について要求される基準を満たすことを保証するという重要な役割を担っているためです。品質管理試験は医薬品開発プロセスを通じて必須であり、規制遵守のために不可欠であるため、製薬業界ではアウトソーシングの重要な焦点となっています。高品質で信頼性の高い製品に対する需要の高まりが、こうしたサービスへの継続的なニーズを促し、その重要性をさらに確固たるものにしています。

同市場は、試験の種類によって4つのカテゴリーに分類されます：すなわち、原料試験、完成品試験、臨床試験、包装試験です。医薬品分析試験アウトソーシング市場における試験タイプの中では、最終製品試験が最も顕著で重要なセグメントです。これは、消費者に流通する最終医薬品の品質、安全性、有効性に直接影響するためです。FDAなどの規制機関は、安全基準の遵守を保証し、意図したとおりの性能を確認するために、最終製品の厳格な試験を要求しています。製薬会社はこうした規制要件を満たすべく努力しており、最終製品試験のアウトソーシングは、市場における効率性と信頼性を確保するための重要な戦略となっています。

医薬品分析試験アウトソーシング市場：地域別分析

北米の医薬品分析試験アウトソーシング市場は、医薬品開発の複雑化、コスト最適化の必要性、試験技術の進歩などの要因によって着実に成長しています。米国は堅調な製薬産業、高いヘルスケア支出、確立された規制の枠組みにより、この地域を支配しています。アウトソーシングは、企業がコストを管理し、業務効率を向上させ、分析試験に関する専門知識を利用するのに役立ちます。さらに、バイオ医薬品やジェネリック医薬品に対する需要の高まりも、市場の拡大を後押ししています。

この地域の主要プレーヤーには、安定性試験から品質管理まで幅広いサービスを提供する世界な受託試験機関が含まれます。規制基準が厳しくなるにつれ、製薬会社はコンプライアンスを確保し、市場投入までの時間を短縮するため、第三者サービスへの依存度を高めています。製薬企業とアウトソーシング・プロバイダーとの提携動向の高まりから、同市場は今後も継続的な成長が見込まれます。

北米の医薬品分析試験アウトソーシング市場では米国が優位を占めています。世界最大の製薬産業を誇り、数多くの大手医薬品メーカーやバイオテクノロジー企業が存在します。高度なヘルスケア・インフラ、FDAのような規制機関、研究開発に重点を置くことが、アウトソーシングの需要を後押ししています。米国を拠点とする製薬会社は、規制要件を満たし、医薬品開発プロセスを迅速化するために、試験受託機関を利用することが多く、市場のリーダーシップをさらに強固なものにしています。

医薬品分析試験アウトソーシング市場：競合情勢

医薬品分析試験アウトソーシング市場の競合情勢は、世界的な医薬品開発業務受託機関（CRO）、専門試験ラボ、大手製薬サービスプロバイダーが混在していることが特徴です。Labcorp Drug Development、Charles River Laboratories、Eurofins Scientificのような新興国市場は、試験サービスの幅広いポートフォリオと幅広い地域展開で市場を独占しています。各社は競争に勝ち残るため、高度なデータ分析や自動化などの技術革新を通じて、サービス内容の充実に注力しています。

戦略的提携、合併、買収は、各社が能力の拡大とサービス提供の向上を目指す中で一般的に行われています。加えて、規制への対応や複雑な製剤への対応が差別化要因となっています。小規模でニッチな企業は、バイオ分析および特殊試験サービスにおいて、ますます専門的なニッチを開拓しつつあります。より迅速で費用対効果の高い試験ソリューションへの需要が、各社に効率的なプロセスの採用を促し、競争をさらに激化させています。

目次

第1章 医薬品分析試験アウトソーシング市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 医薬品分析試験アウトソーシングの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 医薬品分析試験アウトソーシング市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 医薬品分析試験アウトソーシング市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 医薬品分析試験アウトソーシングの市場情勢

  • 医薬品分析試験アウトソーシングの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 医薬品分析試験アウトソーシング市場：サービスの種類別

  • 概要
    • セグメント別シェア分析：サービスの種類別
    • 品質管理試験
    • 生体分析試験
    • 安定性試験
    • 試験法開発・検証
    • 規制試験
    • 微生物学的試験

第8章 医薬品分析試験アウトソーシング市場：試験の種類別

  • 概要
    • セグメント別シェア分析：試験の種類別
    • 原材料試験
    • 完成品試験
    • 臨床試験
    • 包装試験

第9章 医薬品分析試験アウトソーシング市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業
    • CRO（医薬品開発業務受託機関）
    • 学術研究機関
    • 政府・規制機関

第10章 医薬品分析試験アウトソーシング市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：医薬品分析試験アウトソーシング業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Labcorp Drug Development
    • Charles River Laboratories
    • WuXi AppTec
    • PPD（Pharmaceutical Product Development）
    • Eurofins Scientific
    • Intertek Group
    • Parexel International
    • Syneos Health
    • Catalent
    • Bioanalytical Systems, Inc.（BASi）
    • Patheon
    • Medpace
    • Pharmaceutical Product Development（PPD）
    • Aptuit
    • Toxikon
    • Frontage Laboratories
    • Covance
    • ICON plc

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4934

REPORT HIGHLIGHT

Pharmaceutical Analytical Testing Outsourcing Market size was valued at US$ 8,530.55 Million in 2024, expanding at a CAGR of 7.70% from 2025 to 2032.

The Pharmaceutical Analytical Testing Outsourcing Market refers to the growing trend of pharmaceutical companies outsourcing their analytical testing services to third-party organizations. These services involve testing the quality, safety, and efficacy of pharmaceutical products, including raw materials, formulations, and finished drugs. By outsourcing, companies can reduce operational costs, enhance efficiency, and access specialized expertise without investing heavily in in-house facilities. Key players in the market include contract research organizations (CROs) and independent testing labs. The market has seen growth due to increasing regulatory requirements, a rise in complex drug formulations, and a need for faster time-to-market. It also helps pharmaceutical companies manage resources effectively while maintaining high-quality standards. Global expansion and technological advancements are expected to drive further growth in this sector.

Pharmaceutical Analytical Testing Outsourcing Market- Market Dynamics

Expansion of generic drug markets boosting analytical testing needs

The expansion of the generic drug market is a significant driver for the pharmaceutical analytical testing outsourcing market. As the demand for affordable medications grows globally, particularly in North America, pharmaceutical companies increasingly focus on developing generic drugs, which requires stringent analytical testing to ensure quality and regulatory compliance. The generic drug industry benefits from lower production costs, and outsourcing analytical testing allows companies to maintain high standards while controlling expenses. Moreover, the increasing pressure to bring generics to market quickly further drives the need for outsourcing, as third-party testing providers offer speed and specialized expertise. According to the U.S. FDA, over 90% of prescriptions in the U.S. are filled with generics, highlighting the vast market size and the corresponding need for reliable and efficient testing. This trend is expected to continue, fueling demand for contract testing services in the coming years.

Pharmaceutical Analytical Testing Outsourcing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.70% over the forecast period (2025-2032)

Based on Service Type segmentation, Quality Control Testing was predicted to show maximum market share in the year 2024

Based on Testing Type segmentation, Finished Product Testing was the leading Testing Type in 2024

Based on End-User segmentation, Pharmaceutical Companies was the leading End-User in 2024

On the basis of region, North America was the leading revenue generator in 2024

Pharmaceutical Analytical Testing Outsourcing Market- Segmentation Analysis:

The Global Pharmaceutical Analytical Testing Outsourcing Market is segmented on the basis of Service Type, Testing Type, End-User, and Region.

The market is divided into six categories based on Service Type: Quality Control Testing, Bioanalytical Testing, Stability Testing, Method Development and Validation, Regulatory Testing, and Microbiological Testing. In the Pharmaceutical Analytical Testing Outsourcing Market, Quality Control Testing is the most significant and dominant segment. This is due to its critical role in ensuring that pharmaceutical products meet the required standards of safety, efficacy, and quality before they reach the market. Quality control testing is mandatory throughout the drug development process and is essential for regulatory compliance, which makes it a key focus for outsourcing in the pharmaceutical industry. The increasing demand for high-quality, reliable products drives a continuous need for these services, further solidifying its prominence.

The market is divided into four categories based on Testing Type: Raw Material Testing, Finished Product Testing, Clinical Trial Testing, and Packaging Testing. Among the testing types in the Pharmaceutical Analytical Testing Outsourcing Market, Finished Product Testing is the most prominent and significant segment. This is because it directly impacts the quality, safety, and efficacy of the final pharmaceutical products that are distributed to consumers. Regulatory agencies, such as the FDA, require stringent testing of finished products to ensure compliance with safety standards and to confirm that they perform as intended. As pharmaceutical companies strive to meet these regulatory requirements, outsourcing of finished product testing becomes a key strategy to ensure efficiency and reliability in the market.

Pharmaceutical Analytical Testing Outsourcing Market- Geographical Insights

The North American pharmaceutical analytical testing outsourcing market is growing steadily, driven by factors such as increasing drug development complexity, the need for cost optimization, and advancements in testing technologies. The U.S. dominates the region due to its robust pharmaceutical industry, high healthcare expenditures, and well-established regulatory frameworks. Outsourcing helps companies manage costs, improve operational efficiency, and gain access to specialized expertise in analytical testing. Further, the rising demand for biopharmaceuticals and generics fuels market expansion.

Key players in the region include global contract testing organizations offering a wide range of services, from stability testing to quality control. As regulatory standards become stricter, pharmaceutical companies increasingly rely on third-party services to ensure compliance and accelerate time-to-market. The market is expected to witness continued growth due to the increasing trend of partnerships between pharmaceutical companies and outsourcing providers.

The United States is the dominant country in the North American pharmaceutical analytical testing outsourcing market. It boasts the largest pharmaceutical industry globally, with numerous leading drug manufacturers and biotech firms. The country's advanced healthcare infrastructure, regulatory bodies like the FDA, and strong emphasis on research and development drive the demand for outsourcing. U.S.-based pharmaceutical companies often turn to contract testing organizations to meet regulatory requirements and expedite drug development processes, further solidifying its market leadership.

Pharmaceutical Analytical Testing Outsourcing Market- Competitive Landscape:

The competitive landscape of the Pharmaceutical Analytical Testing Outsourcing Market is characterized by a mix of global contract research organizations (CROs), specialized testing labs, and large pharmaceutical service providers. Leading players like Labcorp Drug Development, Charles River Laboratories, and Eurofins Scientific dominate the market with their extensive portfolios of testing services and a broad geographical reach. Companies are focusing on enhancing their service offerings through technological innovations, such as advanced data analytics and automation, to stay ahead of the competition.

Strategic collaborations, mergers, and acquisitions are common as firms seek to expand their capabilities and improve service delivery. Additionally, regulatory compliance and the ability to handle complex drug formulations are key differentiators. Smaller and niche players are increasingly carving out specialized niches in bioanalytical and specialized testing services. The demand for faster, cost-effective testing solutions is pushing companies to adopt more efficient processes, further intensifying competition.

Recent Developments:

In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site.

In November 2023, Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, and providing support in the early stages of pharmaceutical product development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBALPHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Labcorp Drug Development
  • Charles River Laboratories
  • WuXi AppTec
  • PPD (Pharmaceutical Product Development)
  • Eurofins Scientific
  • Intertek Group
  • Parexel International
  • Syneos Health
  • Catalent
  • Bioanalytical Systems, Inc. (BASi)
  • Patheon
  • Medpace
  • Pharmaceutical Product Development (PPD)
  • Aptuit
  • Toxikon
  • Frontage Laboratories
  • Covance
  • ICON plc

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Quality Control Testing
  • Bioanalytical Testing
  • Stability Testing
  • Method Development and Validation
  • Regulatory Testing
  • Microbiological Testing

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2019 - 2032

  • Raw Material Testing
  • Finished Product Testing
  • Clinical Trial Testing
  • Packaging Testing

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Government and Regulatory Bodies

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Analytical Testing Outsourcing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Service Type
    • 2.1.2. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Testing Type
    • 2.1.3. Pharmaceutical Analytical Testing Outsourcing Market Snippet by End-User
    • 2.1.4. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Country
    • 2.1.5. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Analytical Testing Outsourcing Key Market Trends

  • 3.1. Pharmaceutical Analytical Testing Outsourcing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Analytical Testing Outsourcing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Analytical Testing Outsourcing Market Opportunities
  • 3.4. Pharmaceutical Analytical Testing Outsourcing Market Future Trends

4. Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Analytical Testing Outsourcing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharmaceutical Analytical Testing Outsourcing Market Landscape

  • 6.1. Pharmaceutical Analytical Testing Outsourcing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Analytical Testing Outsourcing Market - By Service Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service Type, 2024 & 2032 (%)
    • 7.1.2. Quality Control Testing
    • 7.1.3. Bioanalytical Testing
    • 7.1.4. Stability Testing
    • 7.1.5. Method Development and Validation
    • 7.1.6. Regulatory Testing
    • 7.1.7. Microbiological Testing

8. Pharmaceutical Analytical Testing Outsourcing Market - By Testing Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Testing Type, 2024 & 2032 (%)
    • 8.1.2. Raw Material Testing
    • 8.1.3. Finished Product Testing
    • 8.1.4. Clinical Trial Testing
    • 8.1.5. Packaging Testing

9. Pharmaceutical Analytical Testing Outsourcing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Biotechnology Companies
    • 9.1.4. Contract Research Organizations (CROs)
    • 9.1.5. Academic and Research Institutes
    • 9.1.6. Government and Regulatory Bodies

10. Pharmaceutical Analytical Testing Outsourcing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APACMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APACMarket Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APACMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAMMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAMMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEAMarket Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEAMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. IsraelMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. IsraelMarket Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. IsraelMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pharmaceutical Analytical Testing Outsourcing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Labcorp Drug Development
    • 11.2.2. Charles River Laboratories
    • 11.2.3. WuXi AppTec
    • 11.2.4. PPD (Pharmaceutical Product Development)
    • 11.2.5. Eurofins Scientific
    • 11.2.6. Intertek Group
    • 11.2.7. Parexel International
    • 11.2.8. Syneos Health
    • 11.2.9. Catalent
    • 11.2.10. Bioanalytical Systems, Inc. (BASi)
    • 11.2.11. Patheon
    • 11.2.12. Medpace
    • 11.2.13. Pharmaceutical Product Development (PPD)
    • 11.2.14. Aptuit
    • 11.2.15. Toxikon
    • 11.2.16. Frontage Laboratories
    • 11.2.17. Covance
    • 11.2.18. ICON plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us